Five PNNL technologies were recently awarded six R&D 100 honors. The R&D 100 Awards, now in its 58th year, recognize pioneers in science and technology from industry, the federal government, and academia.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.
On World Oceans Day, an international team of marine scientists reports that the potential impact of marine renewable energy to marine life is likely small or undetectable, though some uncertainty remains.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
A new study is among the first to trace the molecular connections between genetics, the gut microbiome and memory in a mouse model bred to resemble the diversity of the human population.
Researchers at PNNL have come up with a novel way to use silicon as an energy storage ingredient, replacing the graphite in electrodes. Silicon can hold 10 times the electrical charge per gram, but it comes with problems of its own.
A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.
Scientists have uncovered a root cause of the growth of needle-like structures—known as dendrites and whiskers—that plague lithium batteries, sometimes causing a short circuit, failure, or even a fire.
A detailed analysis of blood samples from Ebola patients in Sierra Leone is providing clues about the progression of the effects of the virus and potential treatment pathways. The findings point to a critical role for a molecular pathway.
Pacific Northwest National Laboratory and Washington State University researchers have developed a novel way to deliver drugs and therapies into cells at the nanoscale without causing toxic effects that have stymied other such efforts.